biotin has been researched along with Day Blindness in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kellom, ER; Rice, GM; Stepien, KE; Wolf, B | 1 |
| Khan, AO | 1 |
| Arndt, C; Brassat, D; Clavelou, P; De Sèze, J; Debouverie, M; Deburghgraeve, V; Defer, G; Gout, O; Heinzlef, O; Labauge, P; Laplaud, DA; Lebrun-Frenay, C; Moreau, T; Outteryck, O; Papeix, C; Pelletier, J; Sedel, F; Toosy, A; Tourbah, A; Vighetto, A | 1 |
| Canda, E; Eraslan, C; Gokben, S; Serdaroglu, G; Serin, M; Tekgul, H; Tekin, H; Ucar, SK; Yilmaz, S | 1 |
| Duat Rodríguez, A; Martín Reyes, C; Puertas Bordallo, D; Ruiz-Falcó Rojas, ML; Valls Ferrán, MI | 1 |
| Brab, M; Heimann, G; Ramaekers, VT; Rau, G | 1 |
| Dalton, RN; Pike, MG; Rahman, S; Standing, S | 1 |
| Baumgartner, ER; Brab, M; Duran, R; Heimann, G; Ramaekers, VT; Suormala, TM | 1 |
1 trial(s) available for biotin and Day Blindness
| Article | Year |
|---|---|
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.
Topics: Biotin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Multiple Sclerosis; Optic Neuritis; Treatment Outcome; Vision Disorders; Visual Acuity; Vitamin B Complex | 2018 |
7 other study(ies) available for biotin and Day Blindness
| Article | Year |
|---|---|
Reversal of Vision Loss in a 49-Year-Old Man With Progressive Optic Atrophy Due to Profound Biotinidase Deficiency.
Topics: Biotin; Biotinidase; Biotinidase Deficiency; Exome Sequencing; Humans; Male; Middle Aged; Mutation; Optic Atrophy; Vision Disorders; Visual Acuity; Visual Fields; Vitamin B Complex | 2021 |
Juvenile progressive optic atrophy as the presenting feature of biotinidase deficiency, a treatable metabolic disorder.
Topics: Adolescent; Biotin; Biotinidase; Biotinidase Deficiency; Child; Female; Humans; Optic Atrophy; Vision Disorders | 2021 |
A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency.
Topics: Adolescent; Biotin; Biotinidase Deficiency; Diagnosis, Differential; Humans; Male; Neuromyelitis Optica; Spinal Cord Diseases; Treatment Outcome; Vision Disorders | 2017 |
[Optic neuropathy in biotinidase deficiency].
Topics: Biotin; Biotinidase Deficiency; Child; Fundus Oculi; Humans; Male; Optic Nerve Diseases; Treatment Outcome; Vision Disorders; Visual Acuity; Visual Field Tests | 2004 |
Recovery from neurological deficits following biotin treatment in a biotinidase Km variant.
Topics: Administration, Oral; Adolescent; Amidohydrolases; Biotin; Biotinidase; Blood Chemical Analysis; Cognition; Colorimetry; Evoked Potentials, Visual; Follow-Up Studies; Humans; Male; Multiple Carboxylase Deficiency; Muscle Spasticity; Optic Atrophy; Paralysis; Vision Disorders; Visual Acuity | 1993 |
Late presentation of biotinidase deficiency with acute visual loss and gait disturbance.
Topics: Amidohydrolases; Biotin; Biotinidase; Child, Preschool; Female; Gait; Humans; Metabolism, Inborn Errors; Optic Atrophy; Treatment Outcome; Vision Disorders | 1997 |
A biotinidase Km variant causing late onset bilateral optic neuropathy.
Topics: Adolescent; Amidohydrolases; Biotin; Biotinidase; Child; Evoked Potentials, Visual; Female; Humans; Kinetics; Male; Motor Neuron Disease; Optic Nerve Diseases; Paralysis; Vision Disorders; Visual Fields | 1992 |